Skip to main content
. 2021 Oct 29;12:747274. doi: 10.3389/fgene.2021.747274

TABLE 1.

Summary of risk alleles, 1,000 Genome frequencies and SNPs associated with rheumatoid arthritis.

CHR SNP A1/A2 RA (no.) Normal (no.) OR P EAS EUR AFR
6p21.32 rs9268839 A/G 42.4% (1,364) 56.0% (1768) 0.58 (0.53–0.64) 3.95 × 10−27 a 0.354 0.451 0.236
6p21.32 rs9275376 T/G 25.0% (804) 15.7% (496) 1.79 (1.58–2.03) 2.65 × 10−20 a 0.192 0.299 0.285
6q23.3 rs7752903 G/T 6.4% (205) 4.3% (136) 1.51 (1.21–1.89) 2.33 × 10−4 a 0.049 0.019 0.056
6p21.33 rs4947332 T/C 2.2% (72) 1.1% (34) 2.11 (1.4–3.18) 2.78 × 10−4 a 0.012 0.029 0.094
1p13.1 rs1414273 C/T 40.5% (1,303) 44.7% (1,412) 0.84 (0.76–0.93) 8.26 × 10−4 a 0.585 0.140 0.584
15q15.1 rs2620381 C/A 7.9% (254) 10.1% (318) 0.77 (0.65–0.91) 2.55 × 10−3 a 0.086 0.004 0.130
14q32.31 rs75330474 T/C 3.8% (121) 5.0% (159) 0.74 (0.58–0.94) 0.0136 0.065 0.003 0.064
18p11.21 rs370878033 G/A 1.7% (54) 2.6% (81) 0.65 (0.46–0.92) 0.01435 0.032 0.001 0.001
7q22.1 rs3823658 A/G 13.4% (432) 11.5% (363) 1.20 (1.03–1.39) 0.01825 0.138 0.138 0.006
1p32.3 rs74085143 A/G 4.0% (130) 5.3% (166) 0.76 (0.6–0.96) 0.0219 0.048 0.022 0.331
6q23.2 rs7740161 T/A 14.3% (459) 16.3% (515) 0.86 (0.75–0.98) 0.0253 0.102 0.347 0.614
3p21.1 rs4687672 A/G 33.7% (1,082) 31.1% (983) 1.12 (1.01–1.25) 0.02914 0.317 0.264 0.202
22q12.2 rs5997893 A/G 46.9% (1,509) 49.5% (1,565) 0.90 (0.82–1.00) 0.03972 0.498 0.667 0.918
19p13.2 rs2967897 T/C 16.8% (541) 15.0% (473) 1.15 (1.00–1.31) 0.04189 0.849 0.686 0.614
15q25.3 rs76468441 T/C 3.2% (104) 2.4% (76) 1.36 (1.00–1.83) 0.0453 0.042 0.054 0.011
a

FDR corrections were not shown in the table while only p < 2.55 × 10−3 is significant in the table with FDR correction. EAS, EUR, and AFR represent allele frequency of A1 in East Asian, European and African populations based on 1,000 Genome dataset. All the OR and p-value are referring to A1 while taking A2 as reference. Bayesian logistic regression model adjusted for covariates including gender, age, and BMI, were applied as the statistical approach.